IGF2BP1 and neoplasm: METTL3, YTHDC1, FTO, METTL14, RBM15, YTHDF3, WTAP, HNRNPA2B1, ALKBH5, METTL16, YTHDC2, KIAA1429, IGF2BP3, RBM15B and YTHDF1 had lower expression levels in tumor tissues, while IGF2BP2, IGF2BP1 and HNRNPC had higher expression level in tumor tissues.